Problem

Hospitals and health systems often cannot reliably determine whether payer remittances match the complicated terms they negotiated. Manual audits sample only a fraction of claims, allowing systematic underpayments, missed modifiers and carve-outs, and wrongful denials to persist; Benchify cites potential net revenue loss of 1–11% from underpayments and a narrow 90–180-day recovery window. The killer use case is finding every underpayment and contractually unsupported denial across historical claims before filing deadlines expire, rather than discovering patterns after much of the recoverable revenue is gone.

Product / Service

Benchify converts payer contracts into executable logic and applies that logic across the revenue cycle. Organizations can submit a contract and sample claims, then receive an initial view within about a week; the platform replays historical claims, verifies payments, flags issues before submission, and explains denials with the relevant contract clause. Its audit workflow is designed to cover all claims rather than rely on sampling, while its monitoring workflow supports real-time payment verification and pre-submission checks. The product is sold through organization-specific pricing based on contracts, volume, and verification needs, with API access and dedicated support; Benchify says it can start without replacing existing systems.

Market

Benchify operates in healthcare revenue-cycle software, specifically payer-contract analytics, claims auditing, payment integrity, underpayment recovery, and denial management. It overlaps with vendors such as MD Clarity’s RevFind, Waystar’s Revenue Capture Suite, FinThrive’s Denials and Underpayments Analyzer, and CostFlex’s Payer Contract Analyzer, although Benchify’s positioning emphasizes making contract language executable across pre-payment, payment, and post-payment workflows rather than only analyzing remittances or managing recoveries.

The company is an early-stage, YC-backed startup: Y Combinator lists it as founded in 2024, part of Summer 2024, active, and a four-person team in San Francisco. A third-party profile reports $500,000 raised, while another estimates $330,000 in 2025 ARR; the latter is not a company disclosure, and public materials do not identify customers or provide audited revenue. Accordingly, Benchify appears commercially engaged rather than demonstrably pre-revenue, but its scale and customer traction remain limited or undisclosed.